文献速递鼻科

激光后鼻神经消融术治疗慢性鼻炎的随机对照试验

Effect of Laser Posterior Nasal Neurolysis for the Treatment of Chronic Rhinitis: A Randomized Controlled Trial.
PubMed 文献 · Int Forum Allergy Rhinol · 2026-03-05

本研究为单中心、前瞻性、单盲、随机假手术对照试验,评估CO2激光后鼻神经(PNN)消融治疗慢性鼻炎的安全性和有效性。共65例患者按2:1随机接受活性治疗(n=43)或假手术(n=22),主要终点为3个月时rTNSS评分变化。结果显示活性组rTNSS下降显著优于假手术组(-4.7 vs -2.6,p=0.002),且PSQI和ESS改善更明显。

要点

  • CO2激光PNN消融可显著降低慢性鼻炎患者3个月rTNSS评分。
  • 活性组rTNSS改善≥50%的应答率显著高于假手术组(65.1% vs 31.8%)。
  • 活性组睡眠质量(PSQI)和嗜睡(ESS)改善均显著优于假手术组。

核心结论

  • CO2激光后鼻神经消融术不良事件轻微,在减轻慢性鼻炎症状负担方面优于假手术。

研究设计与样本

  • 单中心、前瞻性、单盲、随机假手术对照试验。
  • 纳入24小时回顾性rTNSS≥5、流涕≥2、鼻塞≥1的患者,按2:1随机分为活性治疗组(n=43)和假手术组(n=22)。
  • 主要终点为3个月时评分变化。

主要发现

  • 基线rTNSS活性组为8.5(95%CI 7.9-9.1),假手术组为8.2(95%CI 7.4-8.9),p=0.589。
  • 3个月时活性组rTNSS下降-4.7(95%CI -5.5至-3.9),假手术组下降-2.6(95%CI -3.4至-1.8),p=0.002。
  • rTNSS改善≥30%的应答率活性组81.4% vs 假手术组63.6%,p=0.119,无显著差异。
  • 事后分析rTNSS改善≥50%的应答率活性组65.1% vs 假手术组31.8%,p=0.011,差异显著。
  • 随访中活性组PSQI和ESS评分改善均显著优于假手术组(p=0.041和p=0.005)。

临床怎么用

  • 对于符合rTNSS≥5、流涕≥2、鼻塞≥1的慢性鼻炎患者,可考虑CO2激光PNN消融治疗。
  • 该治疗可能改善患者的睡眠质量和日间嗜睡。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: To determine the safety and efficacy of laser ablation of the posterior nasal nerve (PNN) for the treatment of chronic rhinitis. METHODS: This study was a single-center, prospective, single-blinded, randomized sham-controlled trial. Patients with a 24-h reflective Total Nasal Symptom Score (rTNSS) ≧ 5, rhinorrhea ≧ 2, and congestion ≧ 1, were randomized 2:1 to active PNN treatment with a CO2 laser device or a sham procedure. Outcome measures included the rTNSS, Nasal Obstruction Symptom Evaluation (NOSE), Pittsburgh Sleep Quality Index (PSQI), and Epworth Sleepiness Scale (ESS). The primary endpoint was the change in scores at 3 months. RESULTS: Patients had a mean baseline rTNSS of 8.5 (95% CI, 7.9-9.1) and 8.2 (95% CI, 7.4-8.9) (p = 0.589) in the active treatment (n = 43) and sham control (n = 22) arms, respectively. At 3 months, the active treatment arm had a significantly greater decrease in rTNSS -4.7 (95% CI, -5.5 to -3.9) versus -2.6 (95% CI, -3.4 to -1.8) (p = 0.002). While the responder rate (RR, defined as ≧30% improvement rTNSS) was not significantly higher in the active treatment arm (81.4% vs. 63.6%, p = 0.119), post-hoc analysis of RR (≧ 50% improvement) showed a significantly higher rate of 65.1% versus 31.8% (p = 0.011). There were greater improvements in the PSQI and ESS scores for the active arm over the sham arm at follow-ups. (p = 0.041 and 0.005, respectively). CONCLUSIONS: The CO2 laser posterior nasal neurolysis of the PNN area is associated with minimal adverse events and is superior to a sham procedure in reducing the symptom burden of chronic rhinitis.

来源:Int Forum Allergy Rhinol,查看原文。版权归原作者所有。

引用

  1. Liao JY, Wang EY, Hsu YS, et al. Effect of Laser Posterior Nasal Neurolysis for the Treatment of Chronic Rhinitis: A Randomized Controlled Trial. Int Forum Allergy Rhinol. 2026. PMID: 41782470. doi:10.1002/alr.70133

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。